(Q50571757)

15 March 2018

title

Cryoglobulinemia in chronic hepatitis C: clinical aspects and response to treatment with interferon alpha and ribavirin. (English)

1 reference

15 March 2018

1 reference

1 reference

Edison Roberto Parise

1

1 reference

15 March 2018

Ana Cláudia de Oliveira

2

1 reference

15 March 2018

Maria Lúcia Ferraz

3

1 reference

15 March 2018

Aparecido Bernardo Pereira

4

1 reference

15 March 2018

Kátia Ramos Leite

5

1 reference

15 March 2018

publication date

1 March 2007

1 reference

15 March 2018

Revista do Instituto de Medicina Tropical de São Paulo

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 March 2018

volume

49

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

67-72

1 reference

15 March 2018

Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Biologic and clinical significance of cryoglobulins. A report of 86 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Cryoglobulinemia in hepatitis C virus chronic active hepatitis: effects of interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Regression of splenic lymphoma after treatment of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Cryoglobulinaemia and rheumatic manifestations in patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Mixed cryoglobulinaemia associated with hepatitis C virus infection: a predictor factor for treatment with interferon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral Hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

Cryoglobulins in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0036-46652007000200001

10.1590/S0036-46652007000200001

21 January 2018

Identifiers

DOI

1 reference

15 March 2018

1 reference

15 March 2018